Ya-Wei Yuan

Ya-Wei Yuan

Auto-generated profile, based on publicly available information

Ya-Wei Yuan

Department of Radiation Oncology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong Province 510515, China

Research Focus & Metrics

Academic Career Length

25Years (2002-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 April 2011 in Experimental Biology and Medicine
Verified
Journal Article
Closed access
JZJun-Fang Zhan
Jun-Fang Zhan
LCLong-Hua Chen
Long-Hua Chen
YYYa-Wei Yuan
Ya-Wei Yuan
GXGuo-Zhu Xie
Guo-Zhu Xie
ASAi-Min Sun
Ai-Min Sun
ZCZhi-Xian Chen
Zhi-Xian Chen
Breast cancer-initiating cells are a relatively radioresistant subpopulation of breast cancer cells. However, the mechanism of this radioresistance is still unclear. This study aimed to investigate the effect of radiation on the levels of signal transducer and activator of transcription 1 (STAT1) in mammospheres of cancer-initiating cells and monolayer cultures of MCF-7 cells. We isolated CD44+/CD24−/low cancer-initiating cells from MCF-7 cells and propagated them as mammospheres. Next we used realtime quantitative reverse-transcriptase polymerase chain reaction to examine the mRNA level of STAT1 in mammospheres of breast cancer-initiating cells and monolayer cultures of MCF-7 cells. The apoptosis rate and surviving fraction using clonogenic assays was observed after treating the cells with a STAT1 inhibitor. After irradiation, the STAT1 level in the mammospheres was higher than that in the monolayer cultures. STAT1 inhibitor treatment did not cause significant changes in the apoptosis rate and surviving fraction in the MCF-7 monolayer cultures. However, the inhibitor treatment caused significant differences in the apoptosis rate and surviving fraction in mammospheres. Our study provides the first evidence that STAT1 signaling contributes to radioresistance in breast cancer-initiating cells and reveals STAT1 as a promising target to reduce radioresistance and enhance the efficacy of radiotherapy for breast cancer.

1 April 2011
Verified
Journal Article
Closed access
QSQuan-Quan Sun
Quan-Quan Sun
XLXiong Liu
Xiong Liu
YLYing Liu
Ying Liu
LWLu Wang
Lu Wang
XPXin-Yu Peng
Xin-Yu Peng
YYYa-Wei Yuan
Ya-Wei Yuan

1 January 2011
Verified
Journal Article
Closed access
YTYun-Hong Tian
Yun-Hong Tian
GXGuozhu Xie
Guozhu Xie
CRChen Ren
Chen Ren
QSQuan-Quan Sun
Quan-Quan Sun
ASAi-Min Sun
Ai-Min Sun
YYYa-Wei Yuan
Ya-Wei Yuan

1 February 2002
Verified
Journal Article
Closed access
ASAi-Min Sun
Ai-Min Sun
YYYa-Wei Yuan
Ya-Wei Yuan
CLChuan-Gang Li
Chuan-Gang Li
JCJun Chen
Jun Chen
MXMing-Xing Xiao
Ming-Xing Xiao
MZMin-Fang Zhao
Min-Fang Zhao